Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure

Clinical trial NCT00171106 · COMPLETED

Trial details

NCT number: NCT00171106
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diastolic Dysfunction, Symptomatic Heart Failure

Start date: 2002-12-01
Primary completion: 2007-08-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.